Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns

Nir Erdinest, Naomi London*, Nadav Levinger, Itay Lavy, Eran Pras, Yair Morad

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The COVID-19 pandemic of 2020 and its' accompanied lockdowns impacted the entire globe in ways the world is only beginning to comprehend. In Israel, children age 9–15 had not been in a frontal classroom and been socially restricted from March 2020 till March 2021. Fourteen of these children that had been under myopia control treatment which had been effective prior to the pandemic were included in this retrospective study to learn if their myopia continued to stay under control, or if the unique environmental modifications affected their progression. The results showed that average increase in spherical equivalent refraction and axial length, measured with optical biometer OA-2000 (Tomey GmbH, Nagoya, Japan), during the year of lockdowns was −0.73 ± 0.46D/0.46 ± 0.31 mm respectively, while the average increase in the year prior was −0.33 ± 0.27D/0.24 ± 0.21 mm. Though several articles have indicated the pandemic environment has influenced myopia progression in children, this communication indicates a possible significant impact of the environment on myopia increase even in individuals under effective atropine treatment. These children's' progression suggests practitioners consider and address multiple aspects simultaneously when attempting myopia control.

Original languageEnglish
Article number101475
JournalContact Lens and Anterior Eye
Issue number4
StatePublished - Aug 2022
Externally publishedYes


  • Home-education
  • Lockdowns
  • Myopia control
  • Myopia progression


Dive into the research topics of 'Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns'. Together they form a unique fingerprint.

Cite this